1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Someya, T. Muto, Y. Inoue, M. Kigawa, T. Terada, T. Shirouzu, M. Yokoyama, S. RIKEN Structural Genomics/Proteomics Initiative (RSGI) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 Solution Structure of the RNA recognition motif in Peptidyl-prolyl cis-trans isomerase E 10.2210/pdb2cqb/pdb pdb_00002cqb 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 11018.311 Peptidyl-prolyl cis-trans isomerase E 5.2.1.8 RNA recognition motif 1 man polymer PPIase E, Rotamase E, Cyclophilin E, Cyclophilin 33 no no GSSGSSGMATTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELF GRTIRVNLAKPMRIKESGPSSG GSSGSSGMATTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELF GRTIRVNLAKPMRIKESGPSSG A hss001001135.1 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample Cell-free protein synthesis PPIE 9606 Homo sapiens PLASMID P040517-01 RIKEN Structural Genomics/Proteomics Initiative RSGI NPPSFA, National Project on Protein Structural and Functional Analyses database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2005-11-19 1 1 2008-04-30 1 2 2011-07-13 1 3 2022-03-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details HELIX DETERMINATION METHOD: AUTHOR DETERMINED SHEET DETERMINATION METHOD: AUTHOR DETERMINED Y PDBJ Y PDBJ 2005-05-19 REL REL target function, structures with the lowest energy, structures with the least restraint violations 100 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 120mM 7.0 ambient 298 K torsion angle dynamics, restrainted molecular dynamics 1 lowest energy 1.16mM PROTEIN U-15N,13C; 20mM d-Tris-HCL(pH7.0); 100mM NaCl; 1mM d-DTT; 0.02% NaN3; 10% D2O 90% H2O/10% D2O Bruker collection XwinNMR 3.5 Delaglio, F. processing NMRPipe 20030801 Johnson, B.A. data analysis NMRView 5.0.4 Kobayashi, N. data analysis KUJIRA 0.9295 Guntert, P. structure solution CYANA 2.0.17 Guntert, P. refinement CYANA 2.0.17 700 Bruker AVANCE GLY -6 n 1 GLY -6 A SER -5 n 2 SER -5 A SER -4 n 3 SER -4 A GLY -3 n 4 GLY -3 A SER -2 n 5 SER -2 A SER -1 n 6 SER -1 A GLY 0 n 7 GLY 0 A MET 1 n 8 MET 1 A ALA 2 n 9 ALA 2 A THR 3 n 10 THR 3 A THR 4 n 11 THR 4 A LYS 5 n 12 LYS 5 A ARG 6 n 13 ARG 6 A VAL 7 n 14 VAL 7 A LEU 8 n 15 LEU 8 A TYR 9 n 16 TYR 9 A VAL 10 n 17 VAL 10 A GLY 11 n 18 GLY 11 A GLY 12 n 19 GLY 12 A LEU 13 n 20 LEU 13 A ALA 14 n 21 ALA 14 A GLU 15 n 22 GLU 15 A GLU 16 n 23 GLU 16 A VAL 17 n 24 VAL 17 A ASP 18 n 25 ASP 18 A ASP 19 n 26 ASP 19 A LYS 20 n 27 LYS 20 A VAL 21 n 28 VAL 21 A LEU 22 n 29 LEU 22 A HIS 23 n 30 HIS 23 A ALA 24 n 31 ALA 24 A ALA 25 n 32 ALA 25 A PHE 26 n 33 PHE 26 A ILE 27 n 34 ILE 27 A PRO 28 n 35 PRO 28 A PHE 29 n 36 PHE 29 A GLY 30 n 37 GLY 30 A ASP 31 n 38 ASP 31 A ILE 32 n 39 ILE 32 A THR 33 n 40 THR 33 A ASP 34 n 41 ASP 34 A ILE 35 n 42 ILE 35 A GLN 36 n 43 GLN 36 A ILE 37 n 44 ILE 37 A PRO 38 n 45 PRO 38 A LEU 39 n 46 LEU 39 A ASP 40 n 47 ASP 40 A TYR 41 n 48 TYR 41 A GLU 42 n 49 GLU 42 A THR 43 n 50 THR 43 A GLU 44 n 51 GLU 44 A LYS 45 n 52 LYS 45 A HIS 46 n 53 HIS 46 A ARG 47 n 54 ARG 47 A GLY 48 n 55 GLY 48 A PHE 49 n 56 PHE 49 A ALA 50 n 57 ALA 50 A PHE 51 n 58 PHE 51 A VAL 52 n 59 VAL 52 A GLU 53 n 60 GLU 53 A PHE 54 n 61 PHE 54 A GLU 55 n 62 GLU 55 A LEU 56 n 63 LEU 56 A ALA 57 n 64 ALA 57 A GLU 58 n 65 GLU 58 A ASP 59 n 66 ASP 59 A ALA 60 n 67 ALA 60 A ALA 61 n 68 ALA 61 A ALA 62 n 69 ALA 62 A ALA 63 n 70 ALA 63 A ILE 64 n 71 ILE 64 A ASP 65 n 72 ASP 65 A ASN 66 n 73 ASN 66 A MET 67 n 74 MET 67 A ASN 68 n 75 ASN 68 A GLU 69 n 76 GLU 69 A SER 70 n 77 SER 70 A GLU 71 n 78 GLU 71 A LEU 72 n 79 LEU 72 A PHE 73 n 80 PHE 73 A GLY 74 n 81 GLY 74 A ARG 75 n 82 ARG 75 A THR 76 n 83 THR 76 A ILE 77 n 84 ILE 77 A ARG 78 n 85 ARG 78 A VAL 79 n 86 VAL 79 A ASN 80 n 87 ASN 80 A LEU 81 n 88 LEU 81 A ALA 82 n 89 ALA 82 A LYS 83 n 90 LYS 83 A PRO 84 n 91 PRO 84 A MET 85 n 92 MET 85 A ARG 86 n 93 ARG 86 A ILE 87 n 94 ILE 87 A LYS 88 n 95 LYS 88 A GLU 89 n 96 GLU 89 A SER 90 n 97 SER 90 A GLY 91 n 98 GLY 91 A PRO 92 n 99 PRO 92 A SER 93 n 100 SER 93 A SER 94 n 101 SER 94 A GLY 95 n 102 GLY 95 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ASN 66 -92.11 -74.91 1 A MET 85 -53.91 175.04 1 A ARG 86 -170.27 105.08 1 A SER 94 37.85 41.98 2 A ARG 47 -82.70 42.08 2 A ALA 50 -175.16 -176.08 2 A ASN 66 -90.85 -74.30 3 A SER -2 -56.08 175.36 3 A ILE 32 -51.61 100.21 3 A ARG 47 -87.06 42.95 3 A ASP 65 -39.24 -27.00 3 A ASN 66 -99.40 -73.46 3 A ASN 68 -36.21 115.76 3 A LYS 88 -170.27 110.14 4 A THR 3 -134.40 -43.95 4 A THR 4 -166.02 112.70 4 A ASP 65 -39.92 -28.47 4 A ASN 66 -98.07 -71.28 4 A ASN 68 -35.18 117.25 4 A ALA 82 -49.33 158.07 4 A ARG 86 -172.91 129.26 4 A ILE 87 -118.59 69.21 4 A PRO 92 -69.80 3.27 4 A SER 93 74.82 50.95 5 A ASP 19 -39.19 -31.61 5 A PHE 29 -39.47 -73.64 5 A ASN 66 -93.82 -74.91 5 A MET 85 -39.07 142.25 5 A LYS 88 -82.81 36.35 6 A SER -4 -64.52 94.78 6 A SER -2 -79.22 48.25 6 A LYS 5 -134.66 -39.42 6 A PHE 29 -37.14 -72.45 6 A ASN 66 -94.78 -74.32 6 A PRO 92 -69.82 -170.47 7 A SER -2 -48.23 165.52 7 A ALA 2 -131.78 -62.30 7 A THR 4 -46.07 101.08 7 A PHE 29 -43.26 -74.03 7 A ILE 32 -61.65 93.44 7 A ALA 50 -171.70 -179.38 7 A ASN 66 -97.69 -74.52 7 A MET 67 -39.10 -36.84 7 A GLU 89 -172.25 112.06 7 A PRO 92 -69.85 -176.02 8 A ALA 2 -173.05 146.46 8 A LYS 5 -106.46 45.82 8 A ASP 19 -35.80 -39.12 8 A ASP 31 -60.70 75.99 8 A ILE 32 -36.12 119.94 8 A ALA 50 -173.56 -179.63 8 A ASP 65 -49.64 -19.99 8 A ASN 66 -104.49 -74.93 8 A ASN 68 -38.60 113.56 8 A LYS 88 36.94 29.67 8 A SER 93 -162.65 117.25 9 A MET 1 -134.36 -53.04 9 A THR 3 34.32 42.63 9 A ARG 6 -131.64 -36.19 9 A PHE 29 -50.99 -71.09 9 A ASP 31 -117.75 75.19 9 A ILE 32 -35.81 120.06 9 A PRO 38 -69.78 97.57 9 A GLU 44 46.29 29.09 9 A ALA 50 -170.71 -175.29 9 A ASN 66 -104.12 -73.20 9 A ASN 68 -39.75 116.21 9 A ALA 82 -46.05 102.93 9 A LYS 83 -46.01 152.44 10 A SER -2 -59.95 171.35 10 A ILE 32 -51.78 103.13 10 A ARG 47 -85.65 31.35 10 A ASN 66 -98.23 -74.79 10 A ALA 82 -45.11 106.58 10 A LYS 83 -46.87 150.13 10 A GLU 89 -107.66 -61.00 11 A SER -2 -52.81 173.33 11 A LYS 5 -94.32 42.42 11 A PHE 29 -36.36 -70.40 11 A ALA 50 -170.59 -177.51 11 A ASN 66 -98.38 -73.29 11 A SER 93 -122.71 -55.13 12 A SER -2 -64.44 88.83 12 A ALA 2 -61.28 96.63 12 A THR 4 -69.78 70.78 12 A LYS 5 -78.84 48.77 12 A ASP 19 -38.75 -38.21 12 A PHE 29 -49.22 -73.52 12 A ILE 32 -38.71 144.49 12 A ALA 50 -171.20 -176.82 12 A ASP 65 -39.98 -25.36 12 A ASN 66 -102.54 -74.43 12 A ASN 68 -34.77 116.27 12 A ALA 82 -46.89 107.66 12 A LYS 83 -49.98 152.63 12 A SER 94 -166.91 107.08 13 A LYS 5 -98.71 36.84 13 A PHE 29 -52.83 -71.76 13 A ASP 31 -115.00 78.65 13 A ILE 32 -35.88 122.17 13 A ASN 66 -109.35 -74.08 13 A MET 67 -34.78 -32.70 13 A PRO 92 -69.70 -173.56 14 A SER -5 -161.52 114.69 14 A ALA 2 -79.42 46.54 14 A ASN 66 -95.40 -73.01 14 A MET 85 -41.41 151.79 15 A MET 1 -92.56 55.01 15 A LYS 5 -103.11 42.83 15 A ASP 19 -36.13 -38.64 15 A ASN 66 -93.75 -73.25 15 A ARG 86 -32.25 129.42 15 A PRO 92 -69.80 -177.12 16 A SER -4 -174.65 139.62 16 A PHE 29 -38.08 -73.12 16 A ASP 31 -111.60 79.85 16 A ILE 32 -36.93 124.99 16 A ASP 40 -53.91 -176.37 16 A ASP 65 -38.25 -27.21 16 A ASN 66 -101.54 -74.85 16 A PRO 84 -69.76 -163.54 17 A SER -1 -160.97 106.73 17 A MET 1 -40.98 151.87 17 A PHE 29 -43.86 -72.25 17 A ASP 31 -110.08 73.07 17 A ILE 32 -38.24 119.89 17 A ASN 66 -96.30 -74.95 18 A SER -4 -93.53 42.88 18 A MET 1 -41.56 152.98 18 A THR 4 71.43 53.47 18 A LYS 5 -81.46 42.06 18 A GLU 44 39.68 42.00 18 A ASP 65 -37.94 -27.34 18 A ASN 66 -96.07 -74.18 18 A MET 67 -36.66 -32.03 18 A LYS 83 -44.85 155.53 18 A MET 85 -45.05 160.91 19 A SER -4 -87.44 42.12 19 A ASN 66 -93.92 -74.42 19 A MET 67 -37.89 -39.02 19 A PHE 73 46.88 26.24 19 A GLU 89 -172.29 117.32 20 A MET 1 -61.93 97.25 20 A LEU 13 -55.39 -178.29 20 A ILE 32 -39.60 120.75 20 A ASN 66 -94.28 -75.19 20 A SER 90 -122.72 -53.74 Solution Structure of the RNA recognition motif in Peptidyl-prolyl cis-trans isomerase E 1 N N A ASP 19 A ASP 26 HELX_P A ALA 24 A ALA 31 1 1 6 A GLU 58 A GLU 65 HELX_P A MET 67 A MET 74 1 2 10 ISOMERASE RNA recognition motif, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, Isomerase PPIE_HUMAN UNP 1 1 Q9UNP9 MATTKRVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELFGRTIRVN LAKPMRIKE 1 89 2CQB 1 89 Q9UNP9 A 1 8 96 1 cloning artifact GLY -6 2CQB A Q9UNP9 UNP 1 1 cloning artifact SER -5 2CQB A Q9UNP9 UNP 2 1 cloning artifact SER -4 2CQB A Q9UNP9 UNP 3 1 cloning artifact GLY -3 2CQB A Q9UNP9 UNP 4 1 cloning artifact SER -2 2CQB A Q9UNP9 UNP 5 1 cloning artifact SER -1 2CQB A Q9UNP9 UNP 6 1 cloning artifact GLY 0 2CQB A Q9UNP9 UNP 7 1 cloning artifact SER 90 2CQB A Q9UNP9 UNP 97 1 cloning artifact GLY 91 2CQB A Q9UNP9 UNP 98 1 cloning artifact PRO 92 2CQB A Q9UNP9 UNP 99 1 cloning artifact SER 93 2CQB A Q9UNP9 UNP 100 1 cloning artifact SER 94 2CQB A Q9UNP9 UNP 101 1 cloning artifact GLY 95 2CQB A Q9UNP9 UNP 102 4 anti-parallel anti-parallel anti-parallel A LEU 8 A LEU 15 A GLY 11 A GLY 18 A ILE 35 A ILE 42 A ILE 37 A ILE 44 A PHE 49 A PHE 56 A VAL 52 A VAL 59 A ARG 78 A ARG 85 A ASN 80 A ASN 87